Assessment of facility processing environment to determine those areas that have the highest risks.
- Partner with client to develop Investigational New Drug (IND) / Biologics License Applications(BLA) / Computer-mediated communication(CMC) Roadmap (Module 2 and Module 3).
- Assess operational readiness of: Investigational New Drug (IND) / Biologics License Applications(BLA).
- Perform capability assessment to enable: Investigational New Drug (IND) / Biologics License Applications(BLA) / Personal Activity Intelligence(PAI).
- Technical writing and authoring of IND/BLA components.